1. Litwin MS, Tan HJ. The Diagnosis and Treatment of Prostate Cancer: A Review[J]. JAMA. 2017;317(24):2532–42.
2. Malvezzi M, Bertuccio P, Rosso T, et al. European cancer mortality predictions for the year 2015: does lung cancer have the highest death rate in EU women?[J]. Annals of Oncology Official Journal of the European Society for Medical Oncology. 2015;26(4):779.
3. Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J]. CA: A Cancer Journal for Clinicians, 2016, 66(2):115–132.
4. Gosselaar C, Roobol MJ, Roemeling S, et al. The value of an additional hypoechoic lesion-directed biopsy core for detecting prostate cancer[J]. BJU Int. 2008;101(6):685–90.
5. Han M, Chang D, Kim C, et al. Geometric Evaluation of Systematic Transrectal Ultrasound Guided Prostate Biopsy[J]. J Urol. 2012;88(6):2404–9.
6. Gayet M, van der Aa A, Beerlage HP, et al. The value of magnetic resonance imaging and ultrasonography (MRI/US)-fusion biopsy platforms in prostate cancer detection: a systematic review[J]. BJU Int. 2016;117(3):392–400.
7. Tempany CM, Turkbey B, Rosenkrantz AB. The Current State of MR Imaging-targeted Biopsy Techniques for Detection of Prostate Cancer[J]. Radiology. 2017;285(2):343–56.
8. Smeenge M, Tranquart F, Mannaerts CK, et al. First-in-Human Ultrasound Molecular Imaging With a VEGFR2-Specific Ultrasound Molecular Contrast Agent (BR55) in Prostate Cancer[J]. Invest Radiol. 2017;52(7):419–27.
9. Fanti S, Minozzi S, Antoch G, et al. Consensus on molecular imaging and theranostics in prostate cancer[J]. The Lancet Oncology. 2019;19(12):e696–708.
10. Wang LV. Multiscale photoacoustic microscopy and computed tomography[J]. Nat Photonics. 2009;3(9):503–9.
11. Sheng W, Jing L, Tianfu W, et al. Recent Advances in Photoacoustic Imaging for Deep-Tissue Biomedical Applications[J]. Theranostics. 2016;6(13):2394–413.
12. Stoffels I, Morscher S, Helfrich I, et al. Metastatic status of sentinel lymph nodes in melanoma determined noninvasively with multispectral optoacoustic imaging[J]. Sci Transl Med. 2015;7(317):317ra199.
13. Xu M, Wang LV. Photoacoustic imaging in biomedicine[J]. Rev Sci Instrum. 2006;77(4):41101–0.
14. Ni J, Cozzi P, Hung TT, et al. Monitoring Prostate Tumor Growth in an Orthotopic Mouse Model Using Three-Dimensional Ultrasound Imaging Technique[J]. Translational Oncology. 2016;9(1):41–5.
15. Dijkstra BM, Jeltema HJ, Kruijff S, et al. The application of fluorescence techniques in meningioma surgery—a review[J]. Neurosurg Rev. 2018;2019, 42(4):799–809.
16. Zheng C, Zheng M, Gong P, et al. Indocyanine green-loaded biodegradable tumor targeting nanoprobes for in vitro and in vivo imaging[J]. Biomaterials. 2012;33(22):5603–9.
17. Wang H, Liu C, Gong X, et al. In vivo photoacoustic molecular imaging of breast carcinoma with folate receptor-targeted indocyanine green nanoprobes.[J]. Nanoscale. 2014;6(23):14270–9.
18. Desgrosellier JS, Cheresh DA. Integrins in cancer: biological implications and therapeutic opportunities[J]. Nat Rev Cancer. 2010;10(1):9.
19. Sipkins DA, Cheresh DA, Kazemi MR, et al. Detection of tumor angiogenesis in vivo by αvβ3-targeted magnetic resonance imaging[J]. Nat Med. 1998;4(5):623–6.
20. Beer AJ, Haubner R, Sarbia M, et al. Positron emission tomography using [18F]Galacto-RGD identifies the level of integrin αvβ3 expression in man. Clin Cancer Res[J] Clinical Cancer Research. 2006;12(13):3942.
21. Li M, Liu C, Gong X, et al. Linear array-based real-time photoacoustic imaging system with a compact coaxial excitation handheld probe for noninvasive sentinel lymph node mapping[J]. Biomedical Optics Express. 2018;9(4):1408–22.
22. Bai Y, Cong B, Gong X, et al. Compact and low-cost handheld quasibright-field linear-array probe design in photoacoustic computed tomography[J]. J Biomed Opt. 2018;23(12):1–10.
23. Jelena L, Ataya S, Gambhir SS. A high-affinity, high-stability photoacoustic agent for imaging gastrin-releasing peptide receptor in prostate cancer[J]. Clin Cancer Res. 2014;20(14):3721–9.